158 related articles for article (PubMed ID: 10415452)
1. Lactoferrin increases the susceptibility of S. epidermidis biofilms to lysozyme and vancomycin.
Leitch EC; Willcox MD
Curr Eye Res; 1999 Jul; 19(1):12-9. PubMed ID: 10415452
[TBL] [Abstract][Full Text] [Related]
2. Synergy between protamine and vancomycin in the treatment of Staphylococcus epidermidis biofilms.
Lee CK; Rubin LG; Moldwin RM
Urology; 1995 Apr; 45(4):720-4. PubMed ID: 7716861
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of alpha-mangostin in killing and eradicating Staphylococcus epidermidis RP62A biofilms.
Sivaranjani M; Prakash M; Gowrishankar S; Rathna J; Pandian SK; Ravi AV
Appl Microbiol Biotechnol; 2017 Apr; 101(8):3349-3359. PubMed ID: 28343241
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial activities of YycG histidine kinase inhibitors against Staphylococcus epidermidis biofilms.
Qin Z; Lee B; Yang L; Zhang J; Yang X; Qu D; Jiang H; Molin S
FEMS Microbiol Lett; 2007 Aug; 273(2):149-56. PubMed ID: 17578527
[TBL] [Abstract][Full Text] [Related]
5. Eradication of biofilm-forming Staphylococcus epidermidis (RP62A) by a combination of sodium salicylate and vancomycin.
Polonio RE; Mermel LA; Paquette GE; Sperry JF
Antimicrob Agents Chemother; 2001 Nov; 45(11):3262-6. PubMed ID: 11600396
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci.
El-Azizi M; Rao S; Kanchanapoom T; Khardori N
Ann Clin Microbiol Antimicrob; 2005 Jan; 4():2. PubMed ID: 15638934
[TBL] [Abstract][Full Text] [Related]
7. Synergic antistaphylococcal properties of lactoferrin and lysozyme.
Leitch EC; Willcox MD
J Med Microbiol; 1998 Sep; 47(9):837-42. PubMed ID: 9736166
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of telavancin and vancomycin against biofilm-producing Staphylococcus aureus, S. epidermidis, and Enterococcus faecalis strains.
LaPlante KL; Mermel LA
Antimicrob Agents Chemother; 2009 Jul; 53(7):3166-9. PubMed ID: 19451302
[TBL] [Abstract][Full Text] [Related]
9. Comparison of linezolid and vancomycin lock solutions with and without heparin against biofilm-producing bacteria.
Luther MK; Mermel LA; LaPlante KL
Am J Health Syst Pharm; 2017 May; 74(9):e193-e201. PubMed ID: 28438824
[TBL] [Abstract][Full Text] [Related]
10. Elucidation of the antistaphylococcal action of lactoferrin and lysozyme.
Leitch EC; Willcox MDP
J Med Microbiol; 1999 Sep; 48(9):867-871. PubMed ID: 10482299
[TBL] [Abstract][Full Text] [Related]
11. Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro.
Claessens J; Roriz M; Merckx R; Baatsen P; Van Mellaert L; Van Eldere J
Int J Antimicrob Agents; 2015 Apr; 45(4):368-75. PubMed ID: 25614358
[TBL] [Abstract][Full Text] [Related]
12. Synergy of ambroxol with vancomycin in elimination of catheter-related Staphylococcus epidermidis biofilm in vitro and in vivo.
Zhang Y; Fu Y; Yu J; Ai Q; Li J; Peng N; Song S; He Y; Wang Z
J Infect Chemother; 2015 Nov; 21(11):808-15. PubMed ID: 26423688
[TBL] [Abstract][Full Text] [Related]
13. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin].
Kotulová D; Slobodníková L
Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobials as potential adjunctive agents in the treatment of biofilm infection with Staphylococcus epidermidis.
Peck KR; Kim SW; Jung SI; Kim YS; Oh WS; Lee JY; Jin JH; Kim S; Song JH; Kobayashi H
Chemotherapy; 2003 Jul; 49(4):189-93. PubMed ID: 12886054
[TBL] [Abstract][Full Text] [Related]
15. High in vitro antimicrobial activity of β-peptoid-peptide hybrid oligomers against planktonic and biofilm cultures of Staphylococcus epidermidis.
Liu Y; Knapp KM; Yang L; Molin S; Franzyk H; Folkesson A
Int J Antimicrob Agents; 2013 Jan; 41(1):20-7. PubMed ID: 23153961
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity and synergism of lactoferrin and lysozyme against cariogenic microorganisms.
de Andrade FB; de Oliveira JC; Yoshie MT; Guimarães BM; Gonçalves RB; Schwarcz WD
Braz Dent J; 2014; 25(2):165-9. PubMed ID: 25140723
[TBL] [Abstract][Full Text] [Related]
17. MRT letter: Spatial distribution of vancomycin-induced damage in Staphylococcus epidermidis biofilm: an electron microscopic study.
Singh R; Ray P; Das A; Sharma M
Microsc Res Tech; 2010 Jul; 73(7):662-4. PubMed ID: 20572203
[TBL] [Abstract][Full Text] [Related]
18. [In vitro effect of vancomycin and daptomycin on biofilm formation of coagulase-negative staphylococci strains].
Öcal DN; Dolapçı İ; Gençtürk Z; Tekeli A
Mikrobiyol Bul; 2017 Jul; 51(3):220-235. PubMed ID: 28929959
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial Resistance Profile of Planktonic and Biofilm Cells of Staphylococcus aureus and Coagulase-Negative Staphylococci.
de Oliveira A; Cataneli Pereira V; Pinheiro L; Moraes Riboli DF; Benini Martins K; Ribeiro de Souza da Cunha Mde L
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598130
[TBL] [Abstract][Full Text] [Related]
20. Extracellular DNA impedes the transport of vancomycin in Staphylococcus epidermidis biofilms preexposed to subinhibitory concentrations of vancomycin.
Doroshenko N; Tseng BS; Howlin RP; Deacon J; Wharton JA; Thurner PJ; Gilmore BF; Parsek MR; Stoodley P
Antimicrob Agents Chemother; 2014 Dec; 58(12):7273-82. PubMed ID: 25267673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
